Kazia Therapeutics News

Kazia Therapeutics | F-1: Registration statement for securities of certain foreign private issuers

May 29 09:08 ET

Kazia Therapeutics | 424B3: Prospectus

May 23 07:05 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 23 07:05 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 17 16:14 ET

Kazia Therapeutics | 424B3: Prospectus

May 17 16:09 ET

Kazia Therapeutics | 424B3: Prospectus

May 1 16:11 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 1 16:07 ET

Kazia Therapeutics | 424B3: Prospectus

Apr 19 16:35 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 19 16:31 ET

Kazia Therapeutics | 424B3: Prospectus

Mar 27 08:39 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 27 08:29 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 26 08:04 ET

Kazia Therapeutics | 424B3: Prospectus

Feb 21 16:26 ET

Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 21 09:21 ET

Kazia Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 14 15:46 ET

Kazia Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

Feb 12 18:35 ET

Kazia Therapeutics | EFFECT: Others

Feb 6 06:06 ET

Kazia Therapeutics | 424B3: Prospectus

Feb 5 16:25 ET

Kazia Therapeutics | CORRESP: CORRESP

Feb 2 11:50 ET

Kazia Therapeutics | UPLOAD: Others

Feb 1 11:50 ET